American Regent Venofer Injectable Iron Approval Expected In Third Quarter
Executive Summary
American Regent Labs expects FDA approval of the injectable iron product Venofer during the third quarter of 2000.
You may also be interested in...
Watson Ferrlecit
Sodium ferric gluconate injection covered by Medicare as of Dec. 1 as a first-line treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental EPO therapy. HCFA issued a National Coverage Decision for the agent on April 20 (1"The Pink Sheet" May 22, p. 25)
Watson Ferrlecit
Sodium ferric gluconate injection covered by Medicare as of Dec. 1 as a first-line treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental EPO therapy. HCFA issued a National Coverage Decision for the agent on April 20 (1"The Pink Sheet" May 22, p. 25)
Watson To Acquire Schein: Generic Business Projected At $800 Mil. In 2001
Watson expects its generic drug business to top $800 mil. in revenues during 2001 after it completes the proposed acquisition of Schein.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: